medicin compani announc fda approv ionsi fentanyl iontophoret transderm system manag acut postop pain adult patient hospit ionsi first needlefre patientcontrol preprogram fentanyl deliveri systemth medicin compani nasdaqmdco today announc us food drug administr fda approv ionsi fentanyl iontophoret transderm system first needlefre patientcontrol preprogram fentanyl deliveri system shortterm manag acut postop pain adult patient requir opioid analgesia hospit recent survey postsurg patient indic 51 million inpati surgeri perform annual us approxim 65 percent postop patient experi moderatetosever pain1 2accord 2012 analysi ofth premier hospit databas 14 million patient manag pain intraven patientcontrol analgesia ivpca 3howev acut postop pain continu concern patient 53 percent patient survey hospit report anxieti postop pain 4ionsi offer patient recov surgeri hospit control analges dose push button dispens fentanyl transderm via impercept electr current need pain ionsi administ patient hospit enrol ionsi risk evalu mitig strategi rem program intend home use goal ionsi rem mitig risk respiratori depress result accident exposur person prescrib ionsi novel altern tradit ivpca provid needlefre deliveri opioid analgesia creditcards selfadher devic employ impercept electr current deliv ondemand fentanyl said eugen r viscusi md professor anesthesiolog director acut pain manag thoma jefferson univers philadelphia ionsi fit well multimod analges approach allow opioid administr complement nonopioid base therapi simplic devic may make patient mobil physic therapi easier reduc potenti burden associ programm pump accord survey 351 nurs 507 patient present american societi perianesthesia nurs aspan confer 63 percent nurs 56 percent patient said lack mobil drawback ivpca among nurs survey 84 percent said option needlefre postop pain manag system would improv abil care patient 5an import concern nurs treat postop patient effici abl administ patientcontrol analgesia said cecil r pestano rn bsn ccrp nurs manag clinic research beaumont health system ionsi potenti optim nurs care postop patient result high degre nurs satisfact also improv patient mobil ionsi repres novel treatment potenti cornerston manag patient acut postop surgic pain said clive meanwel md phd chairman chief execut offic medicin compani here what possibl believ ionsi potenti chang manag pain hospit patient satisfact increas direct link hospit reimburs critic hospit effect pain manag option avail postsurg patient latest approv serv key part compani purpos contribut econom effici healthcar provid valuebas therapi hospit medicin compani expect ionsi avail us q3 compani discuss approv quarter earn call may 5that 830 confer call avail via phone webcast dial inform list domest dialin 1 877 3599508 intern dialin 1 224 3572393 passcod dialin number 22764656 replay avail 1130 eastern time follow confer call may 12 2015 hear replay call dial 1 855 8592056 domest 1 404 5373406 intern passcod dialin number 22764656 call webcast access via medicin compani websit ionsi fentanyl iontophoret transderm system cii ionsi contain opioid fentanyl compact needlefre preprogram system indic shortterm manag acut postop pain adult patient requir opioid analgesia hospit ionsi use patient alert enough adequ cognit abil understand direct use ionsi home use intend use patient hospit discontinu treatment ionsi patient leav hospit ionsi use patient titrat accept level analgesia use altern opioid analges ionsi administ patient hospit enrol ionsi rem program goal decreas risk respiratori depress result accident exposur person prescrib ensur dispens patient certifi hospit inform health care provid serious risk respiratori depress result accident exposur fentanylth efficaci ionsi establish three placebocontrol trial safeti establish three placebocontrol trial four addit activecontrol random trial import safeti informationwarn hospit use lifethreaten respiratori depress ionsi rem addict abus misus cytochrom p450 3a4 interact life threaten respiratori depress use ionsi may result potenti lifethreaten respiratori depress death result activ drug fentanyl patient activ ionsi dose accident exposur intact ionsi hydrogel compon especi children contact skin contact mucous membran result fatal overdos fentanylkeep reach children ionsi use patient hospit discontinu treatment ionsi patient leav hospit ionsi risk evalu mitig strategi rem program potenti lifethreaten respiratori depress result accident exposur ionsi avail restrict program requir food drug administr call risk evalu mitig strategi rem hospit must enrol program dispens ionsi inform avail call 18774886835 addict abus misuseionsi contain fentanyl schedul ii control substanc abus liabil similar opioid analges ionsi expos user risk addict abus misus lead overdos death assess patient risk prescrib monitor regular develop behavior condit cytochrom p450 3a4 interactionth concomit use ionsi cytochrom p450 3a4 inhibitor may result increas fentanyl plasma concentr could increas prolong advers drug effect may caus potenti fatal respiratori depress addit discontinu concomit use cytochrom p450 3a4 induc may result increas fentanyl plasma concentr monitor patient receiv ionsi cyp3a4 inhibitor inducercontraindicationssignific respiratori depress acut sever bronchial asthma known suspect paralyt ileus gi obstruct hypersensit fentanyl cetylpyridinium chlorid eg cepacol compon ionsyswarn precautionsinteract cns depressantsconcomit use alcohol central nervous system cns depress eg sedat anxiolyt hypnot neurolept otheropioid may caus hypotens profound sedat respiratori depress coma death monitor patient close coadministr requiredrisk injuri mri procedureionsi contain metal part must remov proper dispos mri procedureradiograph imag cardioversiondefibril pacemakersionsi contain metal part andmust remov proper dispos cardiovers defibril avoid damag ionsi strong electromagnet field set procedur ionsi contain radioopaqu compon may interfer xray imag cat scantop skin reaction topic skinreact may occur use ionsi typic limit site applic area reaction general resolv without treatment sever skin reaction observ remov ionsi discontinu useus elder cachect debilit patientslifethreaten respiratori depress like occur elder cachect debilit patient monitor patient close ionsi use concomit drug depress respir use patient chronic pulmonari diseas monitorpati signific chronic obstruct pulmonari diseas cor pulmonal patient substanti decreas respiratori reserv hypoxia hypercapnia preexist respiratori depress respiratori depress particular initi therapi ionsi consid use altern nonopioid analges patient possiblehypotens effect ionsi may causesever hypotens includ orthostat hypotens syncop ambulatori patient increas risk patient whose abil maintain blood pressur alreadi compromis reduc blood volum concurr administr certain cns depress drug eg phenothiazin general anesthet monitor patient initi ionsi patient circulatori shock ionsi may caus vasodil reduc cardiac output blood pressur avoid use ionsi patient circulatori shockpati head injuri increas intracrani pressur ionsi suitabl use inpati alert abl follow direct monitor sedat respiratori depress avoid use ionsi patient impair conscious coma suscept intracrani effect co2retent ionsi may reduc respiratori drive result co2retent increaseintracrani pressur opioid may obscur clinic cours patient head injuri use ionsi caution patient brain tumorsus patient gastrointestin condit ionsi contraind patient gastrointestin obstruct includ paralyt ileus fentanyl may caus spasm sphincter oddi monitor patient biliari tract diseas includ acut pancreat worsen symptom opioid may caus increas serum amylaseus patient convuls seizur disord ionsi may aggrav convuls patient convuls disord may induc aggrav seizur clinic set monitor patient histori seizur disord worsen seizur control ionsi therapi cardiac diseas ionsi may producebradycardia patient monitor patient bradyarrhythmia close chang heart rate particular initi therapi ionsyshepat impairmentinsuffici data areavail use ionsi patient impair hepat function monitor sign sedat respiratori depress patient hepat impair renal impair clinic pharmacologystudi intraven fentanyl patient undergo kidney transplant shown patient high blood urea nitrogen level low fentanyl clearanc monitor sign sedat respiratori depress patient renal impair advers reactionsmost common frequenc 2 headach hypotens nausea vomit anemia dizzi applic site reactionerythema pruritus urinari retentionabout medicin companythemedicin companyspurpos save live allevi suffer contribut econom healthcar focus 3000 lead acuteintens care hospit worldwid vision lead provid solut three area serious infecti diseas care acut cardiovascular care surgeri periop care compani oper theamericaseuropeand themiddl east andasia pacif region global center today inparsippani nj usa andzurichswitzerlandforwardlook statementsstat contain press releas medicin compani pure histor statement pure histor may deem forwardlook statement purpos safe harbor provis privat secur litig reform act 1995 without limit forego word believ anticip expect hope potenti similar express intend identifi forwardlook statement forwardlook statement involv known unknown risk uncertainti may caus compani actual result level activ perform achiev materi differ express impli forwardlook statement import factor may caus contribut differ includ whether physician patient key decis maker accept clinic trial result compani abil success compet potenti competitor may discov develop commerci compet product success compani specif annual alloc quota fentanyl hydrochlorid us drug enforc administr whether third parti compani reli manufactur support develop commerci ionsi abl fulfil oblig compani abl establish maintain arrang factor set forth risk factor detail time time compani period report registr statement file secur exchang commiss includ without limit risk factor detail compani annual report form 10k file sec march 2 2015 incorpor herein refer compani specif disclaim oblig updat forwardlook statements1cent diseas control prevent inpati 2gan tj habib miller te white w apfelbaum jl incid patient satisfact percept postsurg pain result us nation survey curr med res opin 2014301149160 3premier hospit databas tj habib miller te white w apfelbaum jl incid patient satisfact percept postsurg pain result us nation survey curr med res opin 2014301149160 5the american societi perianesthesia nurs aspan orthomcneil inc 2007 mediabob laverti 1 1 communicationsrobertlavertythemedcocomorinvestorrelationsneera dahiya ravindran md 1 9732906044 vicepresid investor relat strateg plan neeraravindranthemedcocom 